Terms: = Lung cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Treatment
396 results:
1. Exploring the Mechanism of Zilongjin in Treating lung Adenocarcinoma Based on Network Pharmacology Combined with Experimental Verification.
Zhang K; Chen X
Crit Rev Immunol; 2024; 44(5):27-40. PubMed ID: 38618726
[TBL] [Abstract] [Full Text] [Related]
2. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
[TBL] [Abstract] [Full Text] [Related]
3. Curcumin-Piperlongumine Hybrid Molecule Increases Cell Cycle Arrest and Apoptosis in lung cancer through JNK/c-jun Signaling Pathway.
Zhang Q; Hui M; Chen G; Huang H; Wang S; Ye Y; Wang Y; Wang M; Zhang S; Huang L; Zhang F; Liu Z
J Agric Food Chem; 2024 Apr; 72(13):7244-7255. PubMed ID: 38517372
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-jun-Zi Decoction in Postoperative Non-Small Cell lung cancer Patients: A Prospective Observational Study.
He Y; Qi A; Gu Y; Zhang C; Wang Y; Yang W; Bi L; Gong Y; Jiao L; Xu L
Integr Cancer Ther; 2024; 23():15347354241237973. PubMed ID: 38504436
[TBL] [Abstract] [Full Text] [Related]
5. Antiproliferative and immunomodulative potential of Citrullus colocynthis and its bioactive compounds in human lymphocytes and lung cells.
Stein C; Voigts J; Niederreiter L; Kowarschik S; Huber R; Lüth VM
J Ethnopharmacol; 2024 Jun; 328():118053. PubMed ID: 38499257
[TBL] [Abstract] [Full Text] [Related]
6. Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.
Moon JW; Hong BJ; Kim SK; Park MS; Lee H; Lee J; Kim MY
Cancer Lett; 2024 Apr; 588():216781. PubMed ID: 38494150
[TBL] [Abstract] [Full Text] [Related]
7. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract] [Full Text] [Related]
8. miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
Turkowski K; Herzberg F; Günther S; Weigert A; Haselbauer T; Fink L; Brunn D; Grimminger F; Seeger W; Sültmann H; Stiewe T; Pullamsetti SS; Savai R
Oncogene; 2024 Apr; 43(16):1178-1189. PubMed ID: 38396293
[TBL] [Abstract] [Full Text] [Related]
9. Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in
Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
[TBL] [Abstract] [Full Text] [Related]
10. RhoGDIβ inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
[TBL] [Abstract] [Full Text] [Related]
11. Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3.
Park WH
Ann Med; 2024 Dec; 56(1):2319853. PubMed ID: 38373208
[TBL] [Abstract] [Full Text] [Related]
12. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer.
Lee K; Choi YJ; Lim HI; Cho KJ; Kang N; Ko SG
BMC Complement Med Ther; 2024 Feb; 24(1):70. PubMed ID: 38303001
[TBL] [Abstract] [Full Text] [Related]
13. Oxfendazole Induces Apoptosis in Ovarian cancer Cells by Activating JNK/MAPK Pathway and Inducing Reactive Oxygen Species Generation.
Chen Y; Wen C; Zhong S; Huang L; Xiang Y; Ou Y; Li L; Tang W; Zhou C; Wu Z; Ye W; Wu S; Huang S; Li Z
Biol Pharm Bull; 2023; 46(11):1569-1575. PubMed ID: 37914359
[TBL] [Abstract] [Full Text] [Related]
14. Notopterol Suppresses IL-17-Induced Proliferation and Invasion of A549 lung Adenocarcinoma Cells via Modulation of STAT3, NF-κB, and AP-1 Activation.
Inthanon S; Dejkriengkraikul P; Yodkeeree S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894738
[TBL] [Abstract] [Full Text] [Related]
15. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
16. [Mechanism of Qilongtian Capsules in treatment of acute lung injury based on network pharmacology prediction and experimental validation].
Xie Y; Su XR; Zhou T; Liang YY; Wu YQ; Wan Y; Lu TL; Zhao XL; Li ZY
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4187-4200. PubMed ID: 37802787
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in lung Adenocarcinoma.
Li HL; Wang JX; Dai HW; Liu JJ; Liu ZY; Zou MY; Zhang L; Wang WR
Chin Med Sci J; 2023 Sep; 38(3):178-190. PubMed ID: 37622313
[TBL] [Abstract] [Full Text] [Related]
18. Transient Receptor Potential Ankyrin 1 (TRPA1) Channel Mediates Acrolein Cytotoxicity in Human lung cancer Cells.
Sakamoto A; Terui Y; Igarashi K; Kashiwagi K
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511605
[TBL] [Abstract] [Full Text] [Related]
19. Cisplatin-based combination therapy for cancer.
Minerva ; Bhat A; Verma S; Chander G; Jamwal RS; Sharma B; Bhat A; Katyal T; Kumar R; Shah R
J Cancer Res Ther; 2023; 19(3):530-536. PubMed ID: 37470570
[TBL] [Abstract] [Full Text] [Related]
20. Phosphorylation of Bcl-2 by JNK confers gemcitabine resistance in lung cancer cells by reducing autophagy-mediated cell death.
Chiu CH; Ramesh S; Liao PH; Kuo WW; Chen MC; Kuo CH; Li CC; Wang TF; Lin YM; Lin YJ; Huang CY
Environ Toxicol; 2023 Sep; 38(9):2121-2131. PubMed ID: 37219008
[TBL] [Abstract] [Full Text] [Related]
[Next]
